Qilu Pharmaceutical (Hainan) Co., Ltd.
Qilu Pharmaceutical (Hainan) Co., Ltd.
Explore linked clinical trials.4 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| QLM2010 Comparative Pharmacokinetic Study With 2-Minute Intravenous Administration | Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Vomiting | Not yet recruiting | Phase 1 | 2026-09-14 | NCT07817004 | |
| Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus | Recruiting | Phase 3 | 2026-03-05 | NCT07258394 | |
| A Phase IV Study of Dimethyl Fumarate Enteric-coated Capsules for Relapsing Multiple Sclerosis (RMS) | Relapsing Multiple Sclerosis | Not yet recruiting | Phase 4 | 2025-08-24 | NCT07138833 | |
| A Study of QLM2011 in Subjects With Advanced Solid Tumors | Advanced Solid Tumors | Not yet recruiting | Phase 1 | 2025-04-17 | NCT06925659 |